S H Kelkar & CompanyQ1 FY25

S H Kelkar & Company Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹128.64P/E: 33.2Market Cap: ₹1.8K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

No

Order

Yes

Capex

Yes

2 of 5 growth signals are positive.

Full analysis

Revenue guidance

Category 3
  • Global Ingredient business expected to grow 10%-12% year-on-year with a robust product pipeline.
  • Overall company revenue growth targeted at 12%-13% CAGR with sustained momentum.
  • Certain new businesses achieving high double-digit growth of 15%-18% annually.
  • Domestic FMCG fragrance segment anticipated to grow around 8% driven by new and startup brands.
  • Capacity expansions (Vashivali and new facility) to enable tripling current volumes in the medium term.
  • Global MNC client base growing steadily though slowly; engagements with large FMCG companies increasing.
  • Global RFQ business has almost doubled revenue since Q4, with potential to exceed USD 10 million annually.
  • Demand outlook for H2 FY25 remains strong with expected double-digit growth continuing in global accounts.
  • The China-plus trend and de-risking policies expected to structurally benefit the business over 3-5 years.

See what S H Kelkar & Company management said on margin guidance — free account, 30 seconds.

Fundraise plans

No
  • There is no mention of any new fundraising through debt or equity in the transcript.
  • Current net debt is around Rs. 540-550 crore, with a potential peak up to Rs. 600-620 crore due to working capital and inventory replenishment.
  • No additional CAPEX envisaged for Vashivali, with Rs. 80 crore planned for the new facility; insurance claim expected to offset losses and help reduce debt.
  • Management expects to reduce debt by about Rs. 100 crore once insurance money is received.
  • Cash flows are robust, and no structural increase in debt is expected; rise in debt is primarily a timing effect.
  • No explicit plans announced for raising fresh equity or new debt instruments at this time.

See what S H Kelkar & Company management said on order book — free account, 30 seconds.

Capex plans

Yes
  • New facility CAPEX is outlined at Rs. 80 crore; no additional CAPEX for Vashivali as it will be covered by insurance.
  • Plan to build a new facility with phased capacity: initially smaller than Vashivali's full capacity, with a later Phase II expansion.
  • Vashivali plant restoration preponed by 2 years; new plant to add capacity parallelly.
  • After completion of both factories, capacity is expected to increase by approximately 20% in Asia, and volume could potentially triple current levels.
  • New factory in Indonesia adds around 10% capacity, shifting some exports from India.
  • The CAPEX aims to meet robust growth and avoid capacity shortfall over the next few years.
  • CAPEX and operational cost savings (OPEX) from leased factories expected to offset each other.
  • Insurance claims for Vashivali fire-related losses will partially or fully cover financial impacts.

Track S H Kelkar & Company — get its next earnings analysis in your feed

How does S H Kelkar & Company rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisS H Kelkar & Company
Rev 3Mar 3

How does S H Kelkar & Company rank in Chemicals & Petrochemicals?

Compare S H Kelkar & Company against every Chemicals & Petrochemicals company (Q1 FY25) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Seya Industries (Q2 FY27)

    Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's

  • DCM Shriram Fine Chemicals (Q2 FY27)

    9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri

  • Dhariwalcorp (Q2 FY27)

    For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…

  • Agastya Energy (Q2 FY27)

    For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →